Outcomes and complications of percutaneous device closure in adults with secundum atrial septal defect
- PMID: 35320204
- DOI: 10.47391/JPMA.106
Outcomes and complications of percutaneous device closure in adults with secundum atrial septal defect
Abstract
Objective: To assess immediate outcome and complications of Amplatzer septal occluder percutaneous device for closure of secundum atrial septal defect in adults, and to determine regression in right ventricular size, reduced pulmonary arterial systolic pressure and incidence of device embolization at follow-up.
Methods: The single-cohort, ambi-directional, observational study was conducted at the Tabba Heart Institute, Karachi, from January 2013 to July 2018, and comprised patients admitted consecutively for percutaneous atrial septal defect closure. Pre-closure trans-oesophageal echocardiogram was performed in all cases to ensure adequacy of defect margins necessary for device stability. Immediate procedure success and complications were determined by trans-oesophageal echocardiogram, while transthoracic echo was done on follow-up. Data was analysed using SPSS 21.
Results: Of the 64 patients, 41(71.9%) were females. The overall mean age was 36.6±14 years. Median size of atrial septal defect was 21mm (interquartile range: 17-26mm). Immediate success was observed in 59(92.2%) patients, and there were 5(8%) acute device embolization events. Small residual atrial septal defect was found in 4(6.3%) cases. On 20-month follow-up, 54(84.4%) patients showed improved symptoms. Repeat transthoracic echo was performed in 39(60.1%) cases, and there were no late embolic events or residual atrial septal defect. Right ventricular size normalized in 34(89.5%) cases, mean pulmonary arterial systolic pressure reduced significantly compared to pre-closure measurement (p<0.001).
Conclusions: Percutaneous atrial septal defect closure was found to be safe and effective in adults with secundum atrial septal defect. Timely closure resulted in improved symptoms, right ventricular remodelling and reduced pulmonary arterial systolic pressure at intermediate-term follow-up.
Keywords: Percutaneous device closure, Secundum ASD..
Similar articles
-
Clinical results of large secundum atrial septal defect closure in adult using percutaneous transcatheter Cocoon atrial septal occluder.J Med Assoc Thai. 2013 Sep;96(9):1127-34. J Med Assoc Thai. 2013. PMID: 24163987
-
Device closure of atrial septal defect with amplatzer septal occluder in adults- safety and outcome.J Ayub Med Coll Abbottabad. 2013 Jul-Dec;25(3-4):48-9. J Ayub Med Coll Abbottabad. 2013. PMID: 25226739
-
Transcatheter closure of secundum atrial septal defect using Cocoon septal occluder: immediate and long-term results.Egypt Heart J. 2022 Aug 13;74(1):59. doi: 10.1186/s43044-022-00298-2. Egypt Heart J. 2022. PMID: 35962873 Free PMC article.
-
Safety and Efficacy of the Amplatzer Septal Occluder: A Systematic Review and Meta-Analysis.Cardiovasc Revasc Med. 2022 Apr;37:52-60. doi: 10.1016/j.carrev.2021.06.002. Epub 2021 Jun 17. Cardiovasc Revasc Med. 2022. PMID: 34183276 Free PMC article.
-
Interventional Therapy Versus Medical Therapy for Secundum Atrial Septal Defect: A Systematic Review (Part 2) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol. 2019 Apr 2;73(12):1579-1595. doi: 10.1016/j.jacc.2018.08.1032. Epub 2018 Aug 16. J Am Coll Cardiol. 2019. PMID: 30121241
Cited by
-
Safety and one-year follow-up analysis of percutaneous ASD closure at a tertiary care hospital.Indian Heart J. 2025 May-Jun;77(3):199-203. doi: 10.1016/j.ihj.2025.03.011. Epub 2025 Mar 27. Indian Heart J. 2025. PMID: 40157568 Free PMC article.
-
Effects of percutaneous closure of atrial septal defects via the right internal jugular vein.Cardiovasc Diagn Ther. 2024 Feb 15;14(1):101-108. doi: 10.21037/cdt-23-282. Epub 2024 Jan 30. Cardiovasc Diagn Ther. 2024. PMID: 38434561 Free PMC article.